Overdiagnosis in Colorectal Cancer Screening - Time to Acknowledge A Blind Spot

Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there...

Full description

Saved in:

Bibliographic Details
Published in:	Gastroenterology (New York, N.Y. 1943) Vol. 155; no. 3; p. 592
Main Authors:	Kalager, Mette, Wieszczy, Paulina, Lansdorp-Vogelaar, Iris, Corley, Douglas A, Bretthauer, Michael, Kaminski, Michal F
Format:	Journal Article
Language:	English
Published:	United States 01.09.2018
Subjects:	Overdiagnosis Colorectal Cancer Screening
ISSN:	1528-0012, 1528-0012
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there is a striking and almost complete lack of knowledge about overdiagnosis in colorectal cancer screening. Overdiagnosis is not part of patient information material, hardly mentioned in guidelines, and not addressed in scientific or public debate. The present paper proposes a semantic, conceptual and clinical framework for overdiagnosis in CRC screening.
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	1528-0012 1528-0012
DOI:	10.1053/j.gastro.2018.07.037